Navigation Links
JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program

PALO ALTO, Calif., March 14, 2007 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that the Journal of the of Cardiology (JACC) has published data from the Ranolazine Open Label Experience (ROLE) program, which showed long-term therapy with Ranexa(R) (ranolazine extended-release tablets) to be safe and well tolerated in patients with chronic stable angina who completed one of two phase 3 clinical trials, and enrolled in the ROLE program.

These data also suggest no evidence of increased mortality attributable to Ranexa based on two year survival rates of ROLE participants compared with published outcomes of similar cohorts used as a reference population.

Because ROLE was an open label study, and not a placebo controlled clinical trial with a comparator group, it does not allow for a rigorous analysis for mortality and it is difficult to fully characterize the implications of the deaths reported in the study.

The ROLE program evaluated 746 patients with chronic angina who chose to receive Ranexa(R) following their participation in the phase 3 Monotherapy Assessment of Ranolazine In Stable Angina (MARISA) or the phase 3 Combination Assessment of Ranolazine In Stable Angina (CARISA) clinical studies with Ranexa. More than 85 percent of eligible MARISA patients and more than 80 percent of eligible CARISA patients chose to receive Ranexa in the ROLE program.

The mean duration of follow-up was 2.82 years and more than 75 percent of ROLE patients completed at least two years of Ranexa therapy. Two years after initial dosing, 9.7 percent of patients had discontinued Ranexa due to adverse events.

No treatment discontinuations occurred due to QT prolongation and no cases of torsades de pointes were reported. The most commonly reported adverse events, other than angina, were dizziness (11.8 percent) and constipation (10.9 percent).

"The high rate of patients choosing
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
2. Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug
3. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
4. The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
5. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
6. Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
7. Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
8. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
9. Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA
10. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
11. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
Post Your Comments:
(Date:8/27/2014)... /PRNewswire-iReach/ -- In a new, interactive guide, DICOM ... the electronic medical record (EMR) and image management ... first-hand, how seamless integration makes diagnostic studies accessible ... http://photos.prnewswire.com/prnh/20140827/140443 "Just five ... within the patient record was near impossible. Fast-forward ...
(Date:8/27/2014)... , Aug. 27, 2014 Varian Medical Systems (NYSE: ... current Salt Lake City manufacturing facility ... of Utah to ultimately create 1,000 ... 20 years. " Utah ... talent, many of whom can be credited with Varian,s success ...
(Date:8/27/2014)... By now, if you haven,t heard about the ... planet. The awareness campaign has brought this devastating disease to ... over $88.5 Million (and counting) for ALS. Every day, more ... starting to as well. One such company, Acorn ... who actually works with ALS sufferers and helps to provide ...
Breaking Medicine Technology:DICOM Grid Launches Interactive Guide to Demonstrate Image-Enabling the EMR 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2
...  Today, Asubio announced the initiation of a landmark ... medication being developed to improve neurological function in ... In accordance with its internal focus ... development activities at a peer-attended symposium at the ...
... Schein, Inc. (NASDAQ: HSIC ), the world,s ... dental, medical and animal health office-based practitioners, celebrated Earth ... program which helps healthcare practitioners more easily use environmentally-friendly ... protecting the health of our planet is an important ...
Cached Medicine Technology:Asubio Initiates Landmark Clinical Study in Spinal Cord Injury 2Asubio Initiates Landmark Clinical Study in Spinal Cord Injury 3Henry Schein Celebrates Earth Day 2Henry Schein Celebrates Earth Day 3
(Date:8/28/2014)... 2014 Every year, cataracts affect over 22 ... the leading cause of blindness in the world. Characterized by ... the iris, cataracts are estimated to affect an additional 30 ... aging population. Cataracts are just one of the many conditions ... Tracy of Carlsbad Eye Care screens patients for a number ...
(Date:8/28/2014)... August 28, 2014 Atlantic Information Services, ... the latest addition to its Management Insight Series, ... Major Patient Privacy/Security Risk . The new report is ... the risks associated with portable electronic devices, and assure ... requirements. , With expert advice on how to conduct ...
(Date:8/28/2014)... Francisco, CA (PRWEB) August 28, 2014 ... by small and mid-sized healthcare organizations, today announced that ... the online appointment company ZocDoc , to head ... the company has created a sales management position. , ... a startup like DoctorBase that already has so much ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Top ... many web hosting companies and announces Bluehost, HostMonster ... recommended suppliers for the webmasters worldwide who want ... rates. , As the world’s most popular server-side ... and many other general-purpose programs. It is now ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 MarijuanaDoctors.com is ... physician, James Patel M.D. of Livermore, California. As always, ... and most qualified physicians, and in accordance with that, ... patients to Dr. Patel’s practice. , Initially finding his ... young age, Dr. Patel was shaped by his mother’s ...
Breaking Medicine News(10 mins):Health News:Cataract Awareness Month an Opportunity to Focus on Vision Care and Ocular Health 2Health News:New Report Offers Best Practices for Avoiding the Patient Privacy/Security Risks Posed by Mobile Devices 2Health News:DoctorBase Hires Josh Angeles as Vice-President of Sales 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4
... Reporter , MONDAY, Dec. 12 (HealthDay News) -- Children of ... birth defects, finds a new study that should allay some ... DNA damage done by chemotherapy and radiation of the reproductive ... damaged genes, researchers say. "We found that DNA damage ...
... 2011) Dr. Rabab Mohsin, an internal medicine resident ... Bailey of the University of Kentucky Gill Heart Institute, ... a large study group of women. Working ... Bailey and fellow investigators identified women who reported arrhythmia ...
... It has been well established that certain lifestyle habits relate ... cancer). In a well-done analysis, the authors estimate the ... of lifestyle and environmental factors. They find that smoking ... cancer, with 19.4% of cancer cases in the UK attributable ...
... NY, December 13, 2011JDRF-funded researchers have begun enrolling adult ... to test whether metformina drug commonly used to treat type ... complications in people with T1D. The REMOVAL study (Reducing ... international trial that will study 500 patients with T1D aged ...
... a bed has to deal with numerous complications. Frequently, ... call them. Bony prominences, such as the sacrum, coccyx ... lead to tissue necrosis. Damage can extend into the ... ulcers are entryways for germs, which can trigger sepsis. ...
... ride into the retina on nanoparticles called dendrimers offers ... retinitis pigmentosa. A collaborative research study among investigators at ... Medicine shows that steroids attached to the dendrimers targeted ... of the eye unaffected and preserving vision. The ...
Cached Medicine News:Health News:Birth Defects Seem Rare in Kids of Childhood Cancer Survivors 2Health News:Birth Defects Seem Rare in Kids of Childhood Cancer Survivors 3Health News:JDRF-funded study seeks to reduce cardiovascular risk 2Health News:Lying and sitting more comfortably 2Health News:Nanoparticles help researchers deliver steroids to retina 2
The perfect quick consult for the busy cardiologist, The Ultimate Echo Guide puts the most clinically essential information in an easy access format....
... a quick-lookup reference for ECG interpretation ... presents the basics (anatomy and physiology ... system of the heart, basic ECG ... algorithms, emergency medications, and comprehensive information ...
Dx/Rx: Heart Failure has tables and figures that summarize important clinical data and current professional society recommendations and up-to-date information for diagnosis and treatment of Heart Fai...
Topics include: ECG reading, ACLS (all the latest protocols and pearls), CHF, acute MI, cardiac testing, palpitations, pericarditis, arrhythmias, murmurs, athletes, valvular disease, endocarditis, sy...
Medicine Products: